If radiation overdose occurs, patients should be advised to drink plenty of water and to void frequently to increase the rate of elimination of the radionuclide.L16393 In certain cases, it may be appropriate to administer a diuretic.L16393
Copper Cu 64 dotatate is a newly approved Cu labeled somatostatin analog and has several advantages over 68Ga-labeled somatostatin analogs for positron emission tomography (PET).A220348 Copper Cu 64 dotatate has a longer half-life and can be produced once a day as opposed to several times a day, and lower positron energy lending to improved spatial resolution.A220348 Further studies should be performed to compare the two tracers.
Further, PET using Copper Cu 64 dotatate has been found to perform better than the current gold standard of single-photon emission computed tomography (SPECT) using 111In-DTPA-octreotide.A220348 In a head-to-head trial, the former tracer detected twice as many lesions as the latter.A220348
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Octreotide | The therapeutic efficacy of Octreotide can be decreased when used in combination with Copper oxodotreotide Cu-64. |
| Vapreotide | The therapeutic efficacy of Vapreotide can be decreased when used in combination with Copper oxodotreotide Cu-64. |
| Pasireotide | The therapeutic efficacy of Pasireotide can be decreased when used in combination with Copper oxodotreotide Cu-64. |
| Lanreotide | The therapeutic efficacy of Lanreotide can be decreased when used in combination with Copper oxodotreotide Cu-64. |
| Somatostatin | The therapeutic efficacy of Somatostatin can be decreased when used in combination with Copper oxodotreotide Cu-64. |